Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Fredrik Enlund"'
Autor:
Anna Thulin, Carola Andersson, Elisabeth Werner Rönnerman, Shahin De Lara, Chaido Chamalidou, Arnd Schoenfeld, Anikó Kovács, Henrik Fagman, Fredrik Enlund, Barbro K. Linderholm
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract There is limited knowledge of the biology of breast cancer (BC) brain metastasis (BM). We primarily aimed to determine the mutations in BCBM and to compare the mutational pattern with the matched primary breast cancer (BC). Secondary aims we
Externí odkaz:
https://doaj.org/article/6421f4558684416ba1fe18b350461d45
Autor:
Anna Thulin, Elisabeth Rönnerman, Chenyang Zhang, Shahin De Lara, Chaido Chamalidou, Arnd Schoenfeldt, Carola Andersson, Anikó Kovács, Fredrik Enlund, Barbro Linderholm
Publikováno v:
Breast, Vol 50, Iss , Pp 113-124 (2020)
Background: Brain metastases (BM) are a feared progression of breast cancer (BC) with impact on quality of life and survival. Despite improved treatments, it is believed patients suffering from BM are increasing. Aims: To study potential changes in t
Externí odkaz:
https://doaj.org/article/e5be4ee1e7c54d0b89b78eb6e8cb6ef3
Autor:
Johan Isaksson, Anders Berglund, Karly Louie, Linda Willén, Arash Hamidian, Anders Edsjö, Fredrik Enlund, Maria Planck, Anders Vikström, Mikael Johansson, Andreas Hallqvist, Gunnar Wagenius, Johan Botling
Publikováno v:
Clinical Lung Cancer.
Background: Real-world data on demographics related to KRAS mutation subtypes are crucial as targeted drugs against the p.G12C variant have been approved. Method: We identified 6183 NSCLC patients with reported NGS-based KRAS status in the Swedish na
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66b157b4ee9088253a3c6755705b362f
https://doi.org/10.1016/j.cllc.2023.05.002
https://doi.org/10.1016/j.cllc.2023.05.002
Autor:
A. Kovács, Arnd Schoenfeldt, Carola Andersson, Fredrik Enlund, Anna Thulin, Barbro Linderholm, Chaido Chamalidou, Shahin De Lara, Elisabeth Werner Rönnerman, Henrik Fagman
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports
Scientific Reports
Purpose: Extensive data of mutations in breast cancer (BC) metastases has been published in recent years. However, these studies contain very few patients with brain metastasis (BM). Thus, there is limited knowledge of the biology of BCBM. We primari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::645f888d0b4884da09eda75272aa999b
https://doaj.org/article/6421f4558684416ba1fe18b350461d45
https://doaj.org/article/6421f4558684416ba1fe18b350461d45
Autor:
Tajana Tešan Tomić, Josefin Olausson, Annica Wilzén, Magnus Sabel, Katarina Truvé, Helene Sjögren, Sándor Dósa, Magnus Tisell, Birgitta Lannering, Fredrik Enlund, Tommy Martinsson, Pierre Åman, Frida Abel
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0175638 (2017)
Pilocytic astrocytoma (PA) is the most common pediatric brain tumor. A recurrent feature of PA is deregulation of the mitogen activated protein kinase (MAPK) pathway most often through KIAA1549-BRAF fusion, but also by other BRAF- or RAF1-gene fusion
Externí odkaz:
https://doaj.org/article/602d8a80ec34443192a88cb2a6baca18
Autor:
Tajana Tešan Tomić, Josefin Olausson, Annica Wilzén, Magnus Sabel, Katarina Truvé, Helene Sjögren, Sándor Dósa, Magnus Tisell, Birgitta Lannering, Fredrik Enlund, Tommy Martinsson, Pierre Åman, Frida Abel
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0184715 (2017)
[This corrects the article DOI: 10.1371/journal.pone.0175638.].
Externí odkaz:
https://doaj.org/article/822b4d2c56cf4b7aaffee268d1c7880d
Autor:
Carola Andersson, Per Hedenström, Riadh Sadik, Ola Nilsson, Bengt Nilsson, Fredrik Enlund, Henrik Sjövall
Publikováno v:
Molecular Diagnosis & Therapy
Background Neoadjuvant tyrosine kinase inhibitor (TKI) therapy increases the chance of organ-preserving, radical resection in selected patients with gastrointestinal stromal tumors (GISTs). We aimed to evaluate systematic, immediate DNA sequencing of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd59395d2ad6c2ce314dd6d59ca05ef7
https://doi.org/10.1007/s40291-020-00451-0
https://doi.org/10.1007/s40291-020-00451-0
Autor:
Shahin De Lara, Anikó Kovács, Carola Andersson, Chenyang Zhang, Chaido Chamalidou, Elisabeth Werner Rönnerman, Arnd Schoenfeldt, Fredrik Enlund, Barbro Linderholm, Anna Thulin
Publikováno v:
The Breast : official journal of the European Society of Mastology
Breast, Vol 50, Iss, Pp 113-124 (2020)
Breast, Vol 50, Iss, Pp 113-124 (2020)
Background Brain metastases (BM) are a feared progression of breast cancer (BC) with impact on quality of life and survival. Despite improved treatments, it is believed patients suffering from BM are increasing. Aims To study potential changes in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6bfb8c80189fd6156ee0bcc23bae399
http://europepmc.org/articles/PMC7375610
http://europepmc.org/articles/PMC7375610
Autor:
Kristina K. Lagerstedt, Erik Kristiansson, Christina Lönnroth, Marianne Andersson, Britt-Marie Iresjö, Annika Gustafsson, Elisabeth Hansson, Ulf Kressner, Svante Nordgren, Fredrik Enlund, Kent Lundholm
Publikováno v:
Cancer Informatics, Vol 2010, Iss 9, Pp 79-91 (2010)
Background: Genetic and epigenetic alterations in colorectal cancer are numerous. However, it is difficult to judge whether such changes are primary or secondary to the appearance and progression of tumors. Therefore, the aim of the present study was
Externí odkaz:
https://doaj.org/article/e2cbca899756430b80ad2cd49d1f115d
Publikováno v:
Cancer Genetics. 209:154-160
Comprehensive genetic profiling by massively parallel sequencing, commonly known as next generation sequencing (NGS), is becoming the foundation of personalized oncology. For sarcomas very few targeted treatments are currently in routine use. In clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::518b8e7b184edde0c9d86d1fae19b268
https://doi.org/10.1016/j.cancergen.2016.02.004
https://doi.org/10.1016/j.cancergen.2016.02.004